| Molecular signaling of ginsenosides Rb Rg and Rg3 and their mode of actions |
43 |
| Pharmacological and medical applications of Panax ginseng and ginsenosides: a review for use in cardiovascular diseases |
35 |
| Functional role of ginseng-derived compounds in cancer |
28 |
| Gut microbiota-mediated pharmacokinetics of ginseng saponins |
24 |
| Bioactivity-guided isolation of ginsenosides from Korean Red Ginseng with cytotoxic activity against human lung adenocarcinoma cells |
21 |
| Beneficial effects of Panax ginseng for the treatment and prevention of neurodegenerative diseases: past findings and future directions |
18 |
| AKT-targeted anti-inflammatory activity of Panax ginseng calyx ethanolic extract |
18 |
| Ginseng and obesity |
18 |
| Compound K, a ginsenoside metabolite, plays an antiinflammatory role in macrophages by targeting the AKT1-mediated signaling pathway |
16 |
| Ginsenoside Rb2 suppresses the glutamate-mediated oxidative stress and neuronal cell death in HT22 cells |
16 |
| Panax ginseng as an adjuvant treatment for Alzheimer's disease |
15 |
| Red ginseng monograph |
15 |
| AKT1-targeted proapoptotic activity of compound K in human breast cancer cells |
14 |
| The skin protective effects of compound K, a metabolite of ginsenoside Rb1 from Panax ginseng |
13 |
| Antimelanogenesis and skin-protective activities of Panax ginseng calyx ethanol extract |
12 |
| BIOGF1K, a compound K-rich fraction of ginseng, plays an antiinflammatory role by targeting an activator protein-1 signaling pathway in RAW264.7 macrophage-like cells |
12 |
| Protective effect of ginsenoside Rb1 against tacrolimus-induced apoptosis in renal proximal tubular LLC-PK1 cells |
11 |
| Ginsenoside compound K protects human umbilical vein endothelial cells against oxidized low-density lipoprotein-induced injury via inhibition of nuclear factor-kappa B, p and JNK MAPK pathways |
11 |
| Multitarget effects of Korean Red Ginseng in animal model of Parkinson's disease: antiapoptosis, antioxidant, antiinflammation, and maintenance of blood-brain barrier integrity |
10 |
| Roles of ginsenosides in inflammasome activation |
10 |
| Micro-/nano-sized delivery systems of ginsenosides for improved systemic bioavailability |
10 |
| Cylindrocarpon destructans/Ilyonectria radicicola-species complex: Causative agent of ginseng root-rot disease and rusty symptoms |
10 |
| Compound K induced apoptosis via endoplasmic reticulum Ca2+ release through ryanodine receptor in human lung cancer cells |
10 |
| Ginsenoside Rh2 epigenetically regulates cell-mediated immune pathway to inhibit proliferation of MCF-7 breast cancer cells |
9 |
| Photoaging protective effects of BIOGF1K, a compound-K-rich fraction prepared from Panax ginseng |
9 |
| Ginsenoside Rb1 ameliorates cisplatin-induced learning and memory impairments |
9 |
| Ginsenoside Rk1 ameliorates paracetamol-induced hepatotoxicity in mice through inhibition of inflammation, oxidative stress, nitrative stress and apoptosis |
9 |
| Biosynthesis of rare 20(R)-protopanaxadiol/protopanaxatriol type ginsenosides through Escherichia coli engineered with uridine diphosphate glycosyltransferase genes |
9 |
| Endophytic Trichoderma citrinoviride isolated from mountain-cultivated ginseng (Panax ginseng) has great potential as a biocontrol agent against ginseng pathogens |
9 |
| Nonsaponin fraction of Korean Red Ginseng attenuates cytokine production via inhibition of TLR4 expression |
8 |
| Ginsenoside Rg(3) promotes inflammation resolution through M2 macrophage polarization |
8 |
| Panax ginseng exerts antidepressant-like effects by suppressing neuroinflammatory response and upregulating nuclear factor erythroid 2 related factor 2 signaling in the amygdala |
8 |
| Ginsenoside Rg1 promotes browning by inducing UCP1 expression and mitochondrial activity in 3T3-L1 and subcutaneous white adipocytes |
8 |
| Qualitative and quantitative analysis of the saponins in Panax notoginseng leaves using ultra-performance liquid chromatography coupled with time-of-flight tandem mass spectrometry and high performance liquid chromatography coupled with UV detector |
8 |
| Synergistic effect of maclurin on ginsenoside compound K induced inhibition of the transcriptional expression of matrix metalloproteinase-1 in HaCaT human keratinocyte cells |
7 |
| Systems-level mechanisms of action of Panax ginseng: a network pharmacological approach |
7 |
| Microemulsion-based hydrogels for enhancing epidermal/dermal deposition of topically administered 20(S)-protopanaxadiol: in vitro and in vivo evaluation studies |
7 |
| Fermentation of red ginseng extract by the probiotic Lactobacillus plantarum KCCM 11613P: ginsenoside conversion and antioxidant effects |
7 |
| High frequency somatic embryogenesis and plant regeneration of interspecific ginseng hybrid between Panax ginseng and Panax quinquefolius |
7 |
| Inhibitory effects of thromboxane A(2) generation by ginsenoside Ro due to attenuation of cytosolic phospholipase A(2) phosphorylation and arachidonic acid release |
7 |
| Korean ginseng extract ameliorates abnormal immune response through the regulation of inflammatory constituents in Sprague Dawley rat subjected to environmental heat stress |
7 |
| Ginsenoside Rg3 suppresses mast cell-mediated allergic inflammation via mitogen-activated protein kinase signaling pathway |
7 |
| Non-clinical pharmacokinetic behavior of ginsenosides |
7 |
| Ginsenosides: the need to move forward from bench to clinical trials |
7 |
| Bioactive lipids in gintonin-enriched fraction from ginseng |
6 |
| Chemical and bioactive comparison of Panax notoginseng root and rhizome in raw and steamed forms |
6 |
| Dammarane-type triterpene oligoglycosides from the leaves and stems of Panax notoginseng and their antiinflammatory activities |
6 |
| Effects of fermented ginseng root and ginseng berry on obesity and lipid metabolism in mice fed a high-fat diet |
6 |
| Applications of Panax ginseng leaves-mediated gold nanoparticles in cosmetics relation to antioxidant, moisture retention, and whitening effect on B16BL6 cells |
6 |
| Ginsenosides from Korean Red Ginseng ameliorate lung inflammatory responses: inhibition of the MAPKs/NF-kappa B/c-Fos pathways |
6 |